ARCHITECT CEA REAGENTS
Carcinoembryonic antigen (CEA) · class III · Until 28/10/2034
- Registration no.
- 10055310933
- Process no.
- 250000240649931
- Status
- Until 28/10/2034
- Device type
- Carcinoembryonic antigen (CEA) (ANTÍGENO CARCINOEMBRIONÁRIO)
- Risk class
- III
- Registration holder
- ABBOTT LABORATORIOS DO BRASIL LTDA CNPJ 56.998.701/0001-16 · 2,467 registrations
- Manufacturer
- Published
- 28/10/1999
- Valid until
- 28/10/2034
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗